street talk page 17 afr "Following CSL's profit upgrade last week a smaller player in the blood plasma sector, Life Therapeutics, has appointed Citigroup to advise it. It comes as the US plasma sector has put its bad days behind it and is in robust form. Given the industry's consolidation, Life and its advisers Citigroup could be working on inviting a bid for the entire business".